UnitedHealth Group (NYSE:UNH) Shares Gap Up Following Earnings Beat

UnitedHealth Group Incorporated (NYSE:UNH)’s share price gapped up prior to trading on Tuesday following a stronger than expected earnings report. The stock had previously closed at $323.48, but opened at $353.01. UnitedHealth Group shares last traded at $354.3990, with a volume of 7,642,045 shares.

The healthcare conglomerate reported $7.23 EPS for the quarter, beating the consensus estimate of $6.76 by $0.47. The company had revenue of $111.65 billion for the quarter, compared to the consensus estimate of $109.84 billion. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The firm’s revenue for the quarter was up 2.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $7.20 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th were given a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date of this dividend was Monday, March 9th. UnitedHealth Group’s payout ratio is presently 67.02%.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q1 earnings and outlook: UNH beat EPS and revenue expectations for Q1 and raised FY‑2026 adjusted earnings guidance (>$18.25), which is the main catalyst for the rally — confirms improving margins and steadier cash generation. VIEW: UnitedHealth’s strong first quarter, forecast raise cheer Wall Street
• Positive Sentiment: Management and cost actions: Management emphasized cost discipline, leadership changes and a $1.5B AI investment to drive efficiency — investors view this as evidence the company can manage medical-cost headwinds and restore margins. UnitedHealth tops quarterly estimates, hikes profit outlook
• Positive Sentiment: Technology tailwind from Optum: Optum Real (AI-first claims/reimbursement platform) is scaling rapidly (hundreds of millions of transactions now, billions expected), which can lower claims friction and improve margins over time. UnitedHealth’s AI Is Rebuilding the Payment Layer of American Healthcare
• Neutral Sentiment: Analyst sentiment and positioning: Several firms have raised targets and reiterated buy ratings ahead of/after the print, supporting momentum but also reflecting expectations already baked into the rally. UnitedHealth Stock (UNH) Surges 7%+ on Q1 Earnings Beat – Here’s Why
• Negative Sentiment: Policy/program uncertainty: UnitedHealth warned of “challenges” around a Medicare obesity-drug pilot program, creating uncertainty about insurer participation and potential cost implications. This is a policy risk for future medical-costs and membership economics. UnitedHealth flags challenges in Medicare obesity drug pilot
• Negative Sentiment: Ongoing cost risks and legacy issues: Although results improved, commentators note medical-cost volatility and recent restructuring means execution risk remains (investors should watch upcoming guidance cadence and membership trends). UnitedHealth Group Reports Flat First-Quarter Earnings

Analysts Set New Price Targets

A number of analysts have issued reports on the stock. Oppenheimer cut their price objective on shares of UnitedHealth Group from $415.00 to $385.00 and set an “outperform” rating for the company in a report on Wednesday, January 28th. Barclays cut their price target on UnitedHealth Group from $391.00 to $327.00 and set an “overweight” rating for the company in a research note on Friday, January 30th. Weiss Ratings lowered UnitedHealth Group from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday, March 2nd. Morgan Stanley reduced their target price on UnitedHealth Group from $411.00 to $409.00 and set an “overweight” rating on the stock in a report on Friday, January 23rd. Finally, Raymond James Financial raised UnitedHealth Group from a “market perform” rating to an “outperform” rating and set a $330.00 price target for the company in a research note on Wednesday, April 1st. One research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $364.79.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of UNH. Sarver Vrooman Wealth Advisors bought a new stake in UnitedHealth Group in the fourth quarter worth approximately $25,000. Beacon Financial Strategies CORP acquired a new stake in shares of UnitedHealth Group in the 4th quarter worth about $26,000. Anfield Capital Management LLC boosted its position in shares of UnitedHealth Group by 220.0% during the fourth quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock valued at $26,000 after buying an additional 55 shares during the last quarter. Joseph Group Capital Management bought a new stake in shares of UnitedHealth Group in the 4th quarter worth $27,000. Finally, Nalls Sherbakoff Group LLC bought a new stake in UnitedHealth Group in the 4th quarter worth about $27,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Trading Up 7.0%

The company has a market capitalization of $314.29 billion, a P/E ratio of 26.25, a price-to-earnings-growth ratio of 1.49 and a beta of 0.40. The firm has a fifty day moving average price of $289.27 and a 200-day moving average price of $316.84. The company has a debt-to-equity ratio of 0.72, a current ratio of 0.79 and a quick ratio of 0.79.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.